Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Feb;22(1):13-6.

Early trials with FK 506 as primary treatment in liver transplantation

S Todo  1 , J J Fung, A J Demetris, A Jain, R Venkataramanan, T E Starzl
Affiliations

Early trials with FK 506 as primary treatment in liver transplantation

S Todo et al. Transplant Proc. 1990 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
Daily dose and blood levels of FK 506 in patients after liver transplantation. I.V., intravenous dose; Oral, oral dose.
Fig 2
Fig 2
Differences of daily steroid dose given to FK 506 patients versus CyA patients.
Fig 3
Fig 3
Postoperative changes of total bilirubin in FK 506 patients versus CyA patients.
Fig 4
Fig 4
Postoperative changes of the SGOT in FK 506 patients versus CyA patients.
Fig 5
Fig 5
Postoperative changes of the GGTP in FK 506 patients versus CyA patients.
Fig 6
Fig 6
Postoperative changes of ALP in the FK 506 patients versus CyA patients.
See this image and copyright information in PMC

References

    1. Starzl TE, Todo S, Fung J, et al. Lancet. 1989;1:1000. - PMC - PubMed
    1. Starzl TE, Gordon RD, Tzakis A, et al. Transplant Proc. 1988;20:131. - PMC - PubMed
    1. Starzl TE, Demetris AJ, Van Thiel DH. N Engl J Med. 1989;321:1014. - PMC - PubMed
    1. Starzl TE, Demetris AJ, Van Thiel DH. N Engl J Med. 1989;321:1092. - PubMed

Publication types

LinkOut - more resources